| Year |
Citation |
Score |
| 2010 |
Cantrell J, Larmonier C, Janikashvili N, Bustamante S, Fraszczak J, Herrell A, Lundeen T, J LaCasse C, Situ E, Larmonier N, Katsanis E. Signaling pathways induced by a tumor-derived vaccine in antigen presenting cells. Immunobiology. 215: 535-44. PMID 19880213 DOI: 10.1016/J.Imbio.2009.09.006 |
0.674 |
|
| 2008 |
Larmonier N, Janikashvili N, LaCasse CJ, Larmonier CB, Cantrell J, Situ E, Lundeen T, Bonnotte B, Katsanis E. Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors. Journal of Immunology (Baltimore, Md. : 1950). 181: 6955-63. PMID 18981115 DOI: 10.4049/Jimmunol.181.10.6955 |
0.621 |
|
| 2008 |
Li G, Andreansky S, Helguera G, Sepassi M, Janikashvili N, Cantrell J, Lacasse CL, Larmonier N, Penichet ML, Katsanis E. A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model. Molecular Cancer Therapeutics. 7: 721-9. PMID 18347157 DOI: 10.1158/1535-7163.Mct-07-2067 |
0.66 |
|
| 2008 |
Larmonier N, Cantrell J, Lacasse C, Li G, Janikashvili N, Situ E, Sepassi M, Andreansky S, Katsanis E. Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. Journal of Leukocyte Biology. 83: 1049-59. PMID 18174364 DOI: 10.1189/Jlb.0907635 |
0.625 |
|
| 2007 |
Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunology, Immunotherapy : Cii. 56: 48-59. PMID 16612596 DOI: 10.1007/S00262-006-0160-8 |
0.749 |
|
| 1987 |
Ribi E, Cantrell JL, Myers KR. 3. Enhancement of tumor immunity with bacterial adjuvants Journal of Industrial Microbiology. 19-29. |
0.348 |
|
| 1982 |
Lichtenstein A, Tuttle R, Cantrell J, Zighelboim J. Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice Journal of the National Cancer Institute. 69: 495-501. PMID 6213807 |
0.379 |
|
| 1979 |
Cantrell JL, McLaughlin CA, Ribi E. Efficacy of Tumor Cell Extracts in lmmunotherapy of Murine EL-4 Leukemia Cancer Research. 39: 1159-1167. PMID 421199 |
0.332 |
|
| 1979 |
Cantrell JL, Wheat RW. Antitumor Activity and Lymphoreticular Stimulation Properties of Fractions Isolated from Corynebacterium parvum Cancer Research. 39: 3554-3563. PMID 225023 |
0.321 |
|
| 1978 |
Cantrell JL, Ribi E, McLaughlin CA. Passive transfer of tumor immunity with spleen cells from guinea pigs cured of hepatocarcinoma by nonspecific immunotherapy Cancer Immunology Immunotherapy. 4: 21-28. DOI: 10.1007/BF00205566 |
0.361 |
|
| 1975 |
Killion JJ, LeFever A, Cantrell JL. Immunotherapy of L1210 leukemia with isolated, antigenic subpopulations of L1210 cells Proceedings of the American Association For Cancer Research. 16. |
0.336 |
|
| Show low-probability matches. |